TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23818488

Group type: EXPERIMENTAL
Intervention: 10% lidocaine applied to the laryngeal surface
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline aerosol
Number of subjects: 54
Study: 21368459

Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 0
Study: 19135496

Group type: EXPERIMENTAL
Intervention: SC599 vaccine 10^5 CFU
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: SC599 vaccine 10^7 CFU
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: SC599 vaccine
Number of subjects: 111
Study: 17920547

Group type: EXPERIMENTAL
Intervention: Antigen-specific therapy targeting myelin proteins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Full-length myelin basic protein or key peptide epitope (residues 83-99)
Number of subjects: 0
Study: 15239532

Group type: EXPERIMENTAL
Intervention: Twice daily chest physiotherapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no chest physiotherapy)
Number of subjects: 32
Study: 12575568

Group type: EXPERIMENTAL
Intervention: Traditional Chinese and Western medicine (TCM-WM) for over 10 months
Number of subjects: 106

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory and analgesic agents
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Traditional Chinese and Western medicine (TCM-WM)
Number of subjects: 106
Study: 9591935

Group type: EXPERIMENTAL
Intervention: Grapefruit juice with 10 mg felodipine ER
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (water with 10 mg felodipine ER)
Number of subjects: 12
Study: 7869288

Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 0
Study: 2533057

Group type: EXPERIMENTAL
Intervention: 200 mg celiprolol daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 400 mg celiprolol daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31268476

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Guselkumab 200 mg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 29137506

Group type: EXPERIMENTAL
Intervention: Labeled Cash Transfer (LCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Labeled Cash Transfer with Commitment (L-CCT)
Number of subjects: 0
Study: 24618054

Group type: EXPERIMENTAL
Intervention: Hydrosurgery system (VERSAJET)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional debridement
Number of subjects: 40
Study: 23265698

Group type: EXPERIMENTAL
Intervention: Peanut SLIT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Crossover subjects receiving peanut SLIT
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Peanut doses through the Week 44 OFCs
Number of subjects: 40
Study: 21593252

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 18845032

Group type: EXPERIMENTAL
Intervention: Bipolar diathermy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Local anaesthesia then pack compression
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Compression of the tonsillar fossae with gauze packs
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Blood-stained saliva presence
Number of subjects: 105
Study: 16478899

Group type: EXPERIMENTAL
Intervention: 20 mg/d of rimonabant
Number of subjects: 3045

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3045
Study: 15246619

Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine (two doses at 2 and 4 months of age)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo (two doses at 2 and 4 months of age)
Number of subjects: 192
Study: 11252647

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 14
Study: 9088653

Group type: EXPERIMENTAL
Intervention: Flunisolide nasal spray 50 micrograms twice/daily (Group 1)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) 10.4 mg three times/day (Group 2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (Group 3)
Number of subjects: 38
Study: 8223830

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 44

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 44
Study: 3011180

Group type: EXPERIMENTAL
Intervention: Lignocaine ointment
Number of subjects: 103

Group type: COMPARATOR
Intervention: Hydrocortisone ointment
Number of subjects: 103

Group type: COMPARATOR
Intervention: Warm sitz baths plus bran
Number of subjects: 103
Study: 30541745

Group type: EXPERIMENTAL
Intervention: Vyxeos (liposomal daunorubicin and cytarabine)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Standard combination of daunorubicin and cytarabine ('7+3')
Number of subjects: 309
Study: 28964827

Group type: EXPERIMENTAL
Intervention: High-velocity, low-load (HVLL) resistance exercise
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low-velocity, high-load (LVHL) resistance exercise
Number of subjects: 9
Study: 27111003

Group type: EXPERIMENTAL
Intervention: Crossword puzzles incorporating 30 veterinary terms
Number of subjects: 42

Group type: COMPARATOR
Intervention: Rote learning with a list of 30 terms and definitions
Number of subjects: 42
Study: 24948348

Group type: EXPERIMENTAL
Intervention: Exposure to major stressful life events (≥ 1 major stressor)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Exposure to major stressful life events (≥ 4 major stressors)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Exposure to major stressful life events
Number of subjects: 497
Study: 20604812

Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures (MIRO) with maxillary dentures (MCD) using two implant-ball attachments (BC)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures (MIRO) with maxillary dentures (MCD) using four implants-bar attachments (BRC)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures (MIRO) with maxillary fixed partial dentures (MFPD) using two implant-ball attachments (BF)
Number of subjects: 35
Study: 20038840

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 876
Study: 18230393

Group type: EXPERIMENTAL
Intervention: Apicectomy with smoothening of the gutta-percha root filling
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Apicectomy with retrograde root filling with mineral trioxide aggregate (MTA)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Overall perception of postoperative discomfort
Number of subjects: 42
Study: 15960212

Group type: EXPERIMENTAL
Intervention: Active management of a labor program (n = 325)
Number of subjects: 975

Group type: COMPARATOR
Intervention: Conventional management (n = 650)
Number of subjects: 975
Study: 12650955

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 10229957

Group type: EXPERIMENTAL
Intervention: Migraine prevalence as assessed by the questionnaire 'Alcoi-92'
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Migraine characteristics as assessed by the questionnaire 'Alcoi-92'
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Associated symptoms of migraine
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Prodromal symptoms of migraine
Number of subjects: 548
Study: 8924287

Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (0.5%)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Topical gentamicin (0.3%)
Number of subjects: 101
Study: 1929137

Group type: EXPERIMENTAL
Intervention: Vialon cannula
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: PTFE-Teflon cannula
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 6822143

Group type: EXPERIMENTAL
Intervention: Clonidine 0.1 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg twice daily (for those not achieving blood pressure goals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg twice daily (for those not achieving blood pressure goals)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine during mental stress testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide during mental stress testing
Number of subjects: 0
Study: 31826195

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation associated with Taigeiko practice (16 sessions)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Taigeiko alone (control group)
Number of subjects: 16
Study: 29151376

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Bipolar tonsillectomy
Number of subjects: 137
Study: 27156201

Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (PP-EES)
Number of subjects: 264
Study: 24695934

Group type: COMPARATOR
Intervention: Community‐based orthopaedic surgeons
Number of subjects: 18

Group type: COMPARATOR
Intervention: Postgraduate year‐5 residents
Number of subjects: 18

Group type: COMPARATOR
Intervention: Postgraduate year‐1 residents
Number of subjects: 18
Study: 22567655

Group type: EXPERIMENTAL
Intervention: Active self-ligating bracket system
Number of subjects: 70

Group type: COMPARATOR
Intervention: Passive self-ligating bracket system
Number of subjects: 70
Study: 18783774

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol (LDL-C)
Number of subjects: 4694

Group type: EXPERIMENTAL
Intervention: Non-high-density lipoprotein cholesterol (non-HDL-C)
Number of subjects: 4694

Group type: EXPERIMENTAL
Intervention: LDL-C and non-HDL-C
Number of subjects: 4694
Study: 17136461

Group type: EXPERIMENTAL
Intervention: electronic Check‐Up to Go (e‐CHUG)
Number of subjects: 106

Group type: COMPARATOR
Intervention: assessment only (control)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: additional 245 abstainers and light drinkers
Number of subjects: 106
Study: 15321806

Group type: EXPERIMENTAL
Intervention: 250 kcal preload
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 750 kcal preload
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0 kcal preload (water)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nutrient preloads (250 kcal and 750 kcal)
Number of subjects: 24
Study: 11295632

Group type: EXPERIMENTAL
Intervention: 4‐hydroxyphenyl retinamide (4‐HPR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9425919

Group type: EXPERIMENTAL
Intervention: Percutaneous acetic acid injection (50% acetic acid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Percutaneous ethanol injection (absolute ethanol)
Number of subjects: 60
Study: 7852977

Group type: EXPERIMENTAL
Intervention: Only children
Number of subjects: 917

Group type: COMPARATOR
Intervention: Sibling children
Number of subjects: 917
Study: 30864645

Group type: EXPERIMENTAL
Intervention: sucrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sucrose + maltodextrin
Number of subjects: 0

Group type: COMPARATOR
Intervention: deionized distilled water (DDW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: maltodextrin
Number of subjects: 0
Study: 29141373

Group type: EXPERIMENTAL
Intervention: 0.08% ropivacaine and 15 μg/ml hydromorphone (H1 group)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 0.10% ropivacaine and 15 μg/ml hydromorphone (H2 group)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 0.12% ropivacaine and 15 μg/ml hydromorphone (H3 group)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 0.12% ropivacaine plus 20 μg/ml hydromorphone (first 50 women)
Number of subjects: 140
Study: 26591685

Group type: EXPERIMENTAL
Intervention: Artemisia vulgaris moxa
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Charcoal moxa
Number of subjects: 38
Study: 23873339

Group type: EXPERIMENTAL
Intervention: Cryotherapy (5 °C ice bath for 20 min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no cryotherapy)
Number of subjects: 20
Study: 21147156

Group type: EXPERIMENTAL
Intervention: 10,000 steps (10K)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 30-minutes (30 min) of continuous physical activity
Number of subjects: 43

Group type: COMPARATOR
Intervention: 30-minutes of activity in bouts of at least 10 minutes (bouts)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 43
Study: 19110953

Group type: EXPERIMENTAL
Intervention: TVT-S surgical method
Number of subjects: 85
Study: 17151159

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 314

Group type: COMPARATOR
Intervention: Switching antipsychotics
Number of subjects: 314
Study: 15529059

Group type: EXPERIMENTAL
Intervention: CPR plus an automated external defibrillator (AED)
Number of subjects: 993

Group type: COMPARATOR
Intervention: CPR only
Number of subjects: 993
Study: 11423920

Group type: EXPERIMENTAL
Intervention: High-Monounsaturated Fatty Acid Diet (H-MUFA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: High-Carbohydrate Diet (H-CHO)
Number of subjects: 27
Study: 8996292

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction
Number of subjects: 0
Study: 8425236

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.5 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal saline (5 ml)
Number of subjects: 84
Study: 3320099

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: saline
Number of subjects: 10

Group type: COMPARATOR
Intervention: non-irrigation
Number of subjects: 10
Study: 29032494

Group type: EXPERIMENTAL
Intervention: Exenatide + insulin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Insulin only
Number of subjects: 30
Study: 27498355

Group type: EXPERIMENTAL
Intervention: BiP 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BiP 15 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BiP 1 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BiP (5 mg and 15 mg)
Number of subjects: 24
Study: 26583145

Group type: EXPERIMENTAL
Intervention: Workplace physical exercise (WORK) performed in groups during working hours for 5 × 10 minutes per week
Number of subjects: 200

Group type: COMPARATOR
Intervention: Home-based physical exercise (HOME) performed during leisure time for 5 × 10 minutes per week
Number of subjects: 200
Study: 23532990

Group type: EXPERIMENTAL
Intervention: Family-Based Intervention (FBI)
Number of subjects: 147

Group type: COMPARATOR
Intervention: General Health Intervention (GHI)
Number of subjects: 147
Study: 20628280

Group type: EXPERIMENTAL
Intervention: LigaSure hemorrhoidectomy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Stapled hemorrhoidopexy
Number of subjects: 68
Study: 18854062

Group type: EXPERIMENTAL
Intervention: Implementation intention (experimental condition)
Number of subjects: 525

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 525
Study: 16621911

Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (5.0 pmol/kg.min) during hyperinsulinemic euglycemic clamp
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (5.0 pmol/kg.min)
Number of subjects: 10
Study: 14647221

Group type: EXPERIMENTAL
Intervention: Water and sanitation facilities
Number of subjects: 25483

Group type: COMPARATOR
Intervention: No water and sanitation facilities
Number of subjects: 25483
Study: 10798540

Group type: EXPERIMENTAL
Intervention: LH-RH agonist monotherapy (leuprorelin acetate depot, 3.75 mg monthly)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: LH-RH agonist in combination with chlormadinone acetate (100 mg/day)
Number of subjects: 151
Study: 8619447

Group type: EXPERIMENTAL
Intervention: Artesunate plus tetracycline (AT)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Quinine plus tetracycline (QT)
Number of subjects: 176
Study: 1558340

Group type: EXPERIMENTAL
Intervention: Triple therapy plus ranitidine
Number of subjects: 109

Group type: COMPARATOR
Intervention: Ranitidine alone
Number of subjects: 109
Study: 3894147

Group type: EXPERIMENTAL
Intervention: Gemeprost (1 mg vaginal pessary)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31765223

Group type: EXPERIMENTAL
Intervention: Online Emotional Freedom Techniques (EFT) intervention over 8 weeks
Number of subjects: 0
Study: 29743076

Group type: EXPERIMENTAL
Intervention: Daily Mile intervention
Number of subjects: 391
Study: 27238921

Group type: EXPERIMENTAL
Intervention: POD treatment (scaling, root planing, and subantimicrobial dose doxycycline)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Adherence to doxycycline therapy
Number of subjects: 22
Study: 25062582

Group type: EXPERIMENTAL
Intervention: Bilateral balanced occlusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Neutrocentric occlusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both occlusal schemes
Number of subjects: 10
Study: 22239416

Group type: COMPARATOR
Intervention: Conventional vaginal native tissue repair
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Vaginal mesh insertion
Number of subjects: 121
Study: 19783106

Group type: EXPERIMENTAL
Intervention: Naltrexone and psychosocial treatment for alcohol dependence
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Naltrexone and psychosocial treatment for comorbid alcohol and cocaine dependence
Number of subjects: 345

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 345
Study: 19041569

Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin (PL-DOX)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional echocardiography
Number of subjects: 16
Study: 16267634

Group type: EXPERIMENTAL
Intervention: Quetiapine (589.7 mg/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Risperidone (4.9 mg/day)
Number of subjects: 44
Study: 12164745

Group type: EXPERIMENTAL
Intervention: UV‐B phototherapy (3-times weekly narrowband TL‐01 UV‐B regimen)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (patients awaiting UV‐B therapy)
Number of subjects: 41
Study: 10087313

Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Granisetron 20 microg/kg
Number of subjects: 44
Study: 7772441

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: lansoprazole 60 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 66
Study: 2193199

Group type: EXPERIMENTAL
Intervention: Insulin treatment (1 unit.kg bw‐1.hr‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no insulin treatment)
Number of subjects: 0
Study: 148436

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tretinoin cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30155866

Group type: EXPERIMENTAL
Intervention: Novel two‐thumb technique (NTTT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard two‐finger technique (TFT)
Number of subjects: 52
Study: 27664940

Group type: EXPERIMENTAL
Intervention: Pocket PATH exposure during year 1
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Reporting abnormal health indicators to clinicians
Number of subjects: 182
Study: 26228496

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid applied to one side during tonsillectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control side (no hyaluronic acid)
Number of subjects: 50
Study: 23928929

Group type: EXPERIMENTAL
Intervention: PSG TKA (group 1)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional TKA (group 2)
Number of subjects: 180
Study: 21407131

Group type: EXPERIMENTAL
Intervention: 30‐min vibration at 100 Hz applied to the Achilles tendon
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rest (control experiment)
Number of subjects: 8
Study: 19894000

Group type: EXPERIMENTAL
Intervention: Bilateral repetitive transcranial magnetic stimulation (1 Hz and 10 Hz)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1 Hz repetitive transcranial magnetic stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10 Hz repetitive transcranial magnetic stimulation
Number of subjects: 30
Study: 17762362

Group type: EXPERIMENTAL
Intervention: Explosive contractions (EXPL)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Slow contractions (SLOW)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Heavy explosive contractions (HEAVYEXPL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 9
Study: 11015150

Group type: EXPERIMENTAL
Intervention: Gradual initiation of TMP/SMX suspension
Number of subjects: 372

Group type: COMPARATOR
Intervention: Routine initiation of double-strength (DS; 160 mg/800 mg) tablets
Number of subjects: 372
Study: 8790092

Group type: EXPERIMENTAL
Intervention: Elevated total serum cholesterol levels or serum low-density lipoprotein cholesterol levels
Number of subjects: 2709

Group type: COMPARATOR
Intervention: Normal serum lipid levels
Number of subjects: 2709

Group type: EXPERIMENTAL
Intervention: Extent of hard exudate
Number of subjects: 2709
Study: 1619985

Group type: EXPERIMENTAL
Intervention: E + C (ephedrine 20 mg/caffeine 200 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study: 6088300

Group type: EXPERIMENTAL
Intervention: Indomethacin 75 mg daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100